AbCellera Biologics (ABCL) Enterprise Value: 3.331B

AbCellera Biologics, Inc. (ABCL)

11.09 -1.18 (-9.62%) USD | NASDAQ | Nov 02, 16:00

11.16 +0.07 (+0.63%) After-Hours: 17:24

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2020. Start Trial.

Date	Value
October 30, 2026	3.331B
October 29, 2026	3.579B
October 28, 2026	3.751B
October 27, 2026	3.503B
October 26, 2026	3.273B
October 23, 2026	3.193B
October 22, 2026	3.055B
October 21, 2026	3.322B
October 20, 2026	3.159B
October 19, 2026	3.227B
October 16, 2026	3.187B
October 15, 2026	3.457B
October 14, 2026	3.362B
October 13, 2026	3.435B
October 12, 2026	3.443B
October 09, 2026	3.415B
October 08, 2026	3.254B
October 07, 2026	3.503B
October 06, 2026	3.601B
October 05, 2026	3.794B
October 02, 2026	3.781B
October 01, 2026	3.834B
September 30, 2026	4.042B
September 29, 2026	4.112B
September 28, 2026	3.837B

Date	Value
September 25, 2026	3.463B
September 24, 2026	3.447B
September 23, 2026	3.343B
September 22, 2026	3.447B
September 21, 2026	3.450B
September 18, 2026	3.441B
September 17, 2026	3.472B
September 16, 2026	3.147B
September 15, 2026	3.067B
September 14, 2026	2.994B
September 11, 2026	2.908B
September 10, 2026	2.776B
September 09, 2026	2.957B
September 08, 2026	3.077B
September 04, 2026	3.073B
September 03, 2026	3.116B
September 02, 2026	3.052B
September 01, 2026	3.027B
August 31, 2026	3.089B
August 28, 2026	3.049B
August 27, 2026	3.371B
August 26, 2026	3.322B
August 25, 2026	3.401B
August 24, 2026	2.822B
August 21, 2026	3.040B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks